MRI CHANGES IN NEWLY DIAGNOSED GLIOBLASTOMA PATIENTS TREATED AS PART OF A PHASE II TRIAL WITH BAVITUXIMAB, RADIATION, AND TEMOZOLOMIDE

被引：0

作者：

Ly, Ina ^{[1
]}

Cardona, Jonathan ^{[2
]}

Beers, Andrew ^{[2
]}

Chang, Ken ^{[2
]}

Brown, James ^{[2
]}

Reardon, David ^{[3
]}

Arrillaga-Romany, Isabel ^{[4
]}

Dietrich, Jorg ^{[1
]}

Forst, Deborah ^{[1
]}

Lee, Eudocia ^{[3
]}

Jordan, Justin ^{[5
]}

Nayak, Lakshmi ^{[3
]}

Wen, Patrick ^{[6
]}

Batchelor, Tracy ^{[4
]}

Kalpathy-Cramer, Jayashree ^{[7
]}

Gerstner, Elizabeth ^{[1
]}

机构：

[1] Massachusetts Gen Hosp, Boston, MA 02114 USA

[2] Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA USA

[3] Dana Farber Canc Inst, Boston, MA 02115 USA

[4] Harvard Med Sch, Massachusetts Gen Hosp, Boston, MA 02115 USA

[5] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA

[6] Harvard Med Sch, Dana Farber Canc Inst, Boston, MA 02115 USA

[7] Athinoula A Martinos Ctr Biomed Imaging, Boston, MA USA

来源：

NEURO-ONCOLOGY | 2018年 / 20卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

NIMG-68

引用

下载

页码：191 / 191

页数：1

共 50 条

[1] MRI changes in patients with newly diagnosed glioblastoma treated as part a Phase II trial with bavituximab, radiation, and temozolomide
Ly, Ina
Cardona, Jonathan
Beers, Andrew
Chang, Ken
Brown, James
Reardon, David
Arrillaga-Romany, Isabel
Dietrich, Jorg
Forst, Deborah
Lee, Eudocia
Jordan, Justin
Nayak, Lakshmi
Wen, Patrick
Batchelor, Tracy
Curry, William
Kalpathy-Cramer, Jayashree
Gerstner, Elizabeth
NEUROLOGY, 2019, 92 (15)
[2] MRI changes in patients with newly diagnosed glioblastoma treated as part of a phase II trial with bavituximab, radiation, and temozolomide.
Ly, Ina
Cardona, Jonathan
Lou, Kevin
Beers, Andrew
Chang, Ken
Brown, James
Reardon, David A.
Arrillaga-Romany, Isabel
Forst, Deborah Anne
Jordan, Justin T.
Lee, Eudocia Quant
Dietrich, Jorg
Nayak, Lakshmi
Wen, Patrick Y.
Chukwueke, Ugonma Nnenna
Batchelor, Tracy
Curry, William T.
Kalpathy-Cramer, Jayashree
Gerstner, Elizabeth Robins
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
[3] Phase 2 trial of bavituximab with chemoradiation and adjuvant temozolomide in newly diagnosed glioblastoma
Ly, Ina
Richardson, Leland
Liu, Mofei
Muzikansky, Alona
Lou, Kevin
Reardon, David A.
Arrillaga-Romany, Isabel
Forst, Deborah Anne
Jordan, Justin T.
Lee, Eudocia Quant
Dietrich, Jorg
Nayak, Lakshmi
Wen, Patrick Y.
Chukwueke, Ugonma Nnenna
Giobbie-Hurder, Anita
Choi, Bryan D.
Batchelor, Tracy
Kalpathy-Cramer, Jayashree
Curry, William T.
Gerstner, Elizabeth R.
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
[4] Phase II trial of erlotinib with temozolomide and radiation in patients with newly diagnosed glioblastoma multiforme
David M. Peereboom
Dale R. Shepard
Manmeet S. Ahluwalia
Cathy J. Brewer
Neeraj Agarwal
Glen H. J. Stevens
John H. Suh
Steven A. Toms
Michael A. Vogelbaum
Robert J. Weil
Paul Elson
Gene H. Barnett
Journal of Neuro-Oncology, 2010, 98 : 93 - 99
[5] Phase II trial of erlotinib with temozolomide and radiation in patients with newly diagnosed glioblastoma multiforme
Peereboom, David M.
Shepard, Dale R.
Ahluwalia, Manmeet S.
Brewer, Cathy J.
Agarwal, Neeraj
Stevens, Glen H. J.
Suh, John H.
Toms, Steven A.
Vogelbaum, Michael A.
Weil, Robert J.
Elson, Paul
Barnett, Gene H.
JOURNAL OF NEURO-ONCOLOGY, 2010, 98 (01) : 93 - 99
[6] Talampanel With Standard Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma: A Multicenter Phase II Trial
Grossman, Stuart A.
Ye, Xiaobu
Chamberlain, Marc
Mikkelsen, Tom
Batchelor, Tracy
Desideri, Serena
Piantadosi, Steven
Fisher, Joy
Fine, Howard A.
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (25) : 4155 - 4161
[7] PHASE I/II TRIAL OF RADIATION THERAPY, TEMOZOLOMIDE AND PEMBROLIZUMAB FOLLOWED BY TEMOZOLOMIDE AND PEMBROLIZUMAB IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA
Dixit, Karan
Kumthekar, Priya
Kruser, Timothy
Bloch, Orin
Chandler, James
Tate, Matthew
Raizer, Jeffrey
NEURO-ONCOLOGY, 2016, 18 : 19 - 19
[8] Phase II Trial of Hypofractionated IMRT With Temozolomide for Patients With Newly Diagnosed Glioblastoma Multiforme
Reddy, Krishna
Damek, Denise
Gaspar, Laurie E.
Ney, Douglas
Waziri, Allen
Lillehei, Kevin
Stuhr, Kelly
Kavanagh, Brian D.
Chen, Changhu
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : 655 - 660
[9] PHASE II TRIAL OF SURVAXM PLUS TEMOZOLOMIDE FOR NEWLY DIAGNOSED GLIOBLASTOMA
Ahluwalia, Manmeet
Ciesielski, Michael J.
Reardon, David A.
Abad, Ajay
Curry, William
Wong, Eric
Peereboom, David
Figel, Sheila
Hutson, Alan
Groman, Adrienne
Withers, Henry
Liu, Song
Belal, Ahmed
Qiu, Jingxin
Mogensen, Kathleen
Schilero, Cathy
Khosla, Atulya
Casucci, Danielle
Mechtler, Laszlo
Fenstermaker, Robert
NEURO-ONCOLOGY, 2022, 24 : 66 - 66
[10] A PHASE I TRIAL OF TIPIFARNIB WITH RADIATION THERAPY, WITH AND WITHOUT TEMOZOLOMIDE, FOR PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA
Nghiemphu, Phioanh Leia
Wen, Patrick Y.
Lamborn, Kathleen R.
Drappatz, Jan
Robins, H. Ian
Fink, Karen
Malkin, Mark G.
Lieberman, Frank S.
DeAngelis, Lisa M.
Torres-Trejo, Alejandro
Chang, Susan M.
Abrey, Lauren
Fine, Howard A.
Demopoulos, Alexis
Lassman, Andrew B.
Kesari, Santosh
Mehta, Minesh P.
Prados, Michael D.
Cloughesy, Timothy F.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (05): : 1422 - 1427

← 1 2 3 4 5 →